Studies on 1,2: 5,6-Dibenzanthracene Induced Mammary Carcinogenesis in Mice
1963

Study of Mammary Cancer Induction in Mice Using 1,2: 5,6-Dibenzanthracene

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): Kamal J. Ranadive, Kumud A. Karande

Primary Institution: Indian Cancer Research Centre

Hypothesis

The study aims to elucidate the mechanism of mammary carcinogenesis induced by 1,2: 5,6-dibenzanthracene (DBA) in different strains of mice.

Conclusion

The study found that DBA significantly accelerated breast tumor incidence in certain strains of mice, while other strains showed little to no effect.

Supporting Evidence

  • DBA accelerated breast tumor incidence significantly in dba(-MTI) virgins (90%) and breeders (70%).
  • Subcutaneous implantation of DBA pellets induced mammary carcinoma in all strains.
  • Ovary painting with DBA did not affect breast tumor incidence.

Takeaway

This study looked at how a chemical called DBA can cause breast cancer in mice, and found that it worked really well in some types of mice but not in others.

Methodology

The carcinogen was administered through cutaneous application, subcutaneous implantation of pellets, and ovary painting in five different inbred strains of mice.

Limitations

The study did not explore the long-term effects of DBA treatment beyond the observed tumor incidences.

Participant Demographics

Five different inbred strains of mice were used: C3H(Jax), dba(-MTI), Strong A, C57(Black), and L(P).

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication